SCHEMBL5389014

SCHEMBL5389014

CC(C)Cc1nnc(NS(=O)(=O)c2ccc(Cl)cc2)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 1.00
KMT2A Q03164 5/20 0.61
MEN1 O00255 4/20 0.61
KLKB1 P03952 1/20 0.61
CTSB P07858 1/20 0.61
ELANE P08246 1/20 0.61
HPGD P15428 1/20 0.58
POLB P06746 1/20 0.57
MAPT P10636 1/20 0.57
RECQL P46063 1/20 0.56
AKT1 P31749 1/20 0.55
LMNA P02545 1/20 0.55
ALOX12 P18054 1/20 0.55
HTT P42858 1/20 0.55
CA1 P00915 1/20 0.55
ATM Q13315 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5410329 0.89 ALDH1A1 (0.81) ALDH1A1HPGDRECQLAKT1CA1
SCHEMBL5389556 0.87 ALDH1A1 (0.77) ALDH1A1KMT2AMEN1HPGDPOLB
SCHEMBL11891684 0.87 ALDH1A1 (0.77) ALDH1A1HPGDRECQLAKT1LMNA
SCHEMBL30209683 0.85 KMT2A (0.80) ALDH1A1KMT2AMEN1KLKB1CTSB
Glysobuzole SCHEMBL1815623 0.85 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1HPGDPOLB
SCHEMBL5391543 0.84 ALDH1A1 (0.72) ALDH1A1KMT2AMEN1HPGDPOLB
SCHEMBL11891683 0.82 AKT1 (0.77) ALDH1A1KMT2AMEN1KLKB1CTSB
SCHEMBL30209709 0.82 RECQL (0.79) ALDH1A1KMT2AMEN1KLKB1CTSB
Butadiazamide SCHEMBL2109869 0.82 ALDH1A1 (0.69) ALDH1A1KMT2AMEN1KLKB1CTSB
SCHEMBL5390639 0.81 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1KLKB1CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173030-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2007-02-06 US claimed
EP-1631558-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2006-03-08 EP claimed
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2005-01-13 US claimed
WO-2004103980-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2004-12-02 WO claimed
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2007-03-22 US disclosed
US-7173030-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2007-02-06 US disclosed
EP-1631558-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2006-03-08 EP disclosed
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2005-01-13 US disclosed
WO-2004103980-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD11B2 ALDH1A1 53/4885KMT2A 3325/4885MEN1 942/4885
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD17B11 ALDH1A1 36/4885KMT2A 3281/4885MEN1 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.